ACTIVE

APOTHEEK LETELLIER

Financial year 2025 · Closed on 30/06/2025

Net result62,9 k €-28,4 %over 1 year
Gross margin241,5 k €+2,4 %over 1 year
Equity254,8 k €+0,1 %over 1 year
Workforce2,0 ETP+17,6 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK LETELLIER is a Public limited company incorporated in 1997. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bruxelles. It employs on average 2,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0462.308.928
Incorporation
31/12/1997
Legal form
Public limited company
Registered office
Rue de Verdun 370
1130 Bruxelles · BruxellesSee on map
Contributed capital
65 000,00 €
Latest accounts
30/06/2025
Average workforce
2,0 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 17 financial years

20252024202320222021
Income statement
Gross margin241,5 k €235,9 k €206,4 k €182,2 k €131,9 k €
EBITDA112,4 k €132,7 k €108,8 k €123,3 k €77,8 k €
Operating result108 k €128,9 k €106,2 k €121,3 k €74,1 k €
Net result62,9 k €87,8 k €83,7 k €117,4 k €60,9 k €
Balance sheet
Equity254,8 k €254,4 k €254,1 k €253,9 k €251,5 k €
Total assets544,3 k €566,6 k €425,2 k €474,7 k €419,4 k €
Cash98,3 k €97,5 k €136,3 k €138,3 k €99,6 k €
Debts287 k €308,7 k €168 k €213,8 k €161,7 k €
Other
Workforce2,0 ETP1,7 ETP2,0 ETP2,0 ETP1,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

2 active · 13 ended

Active mandates

Letellier Pharma

Managing director · 0554.748.443

Represented by Eric Letellier

Active
Nicolas Sterckx

Director

Active

Ended mandates

Letellier Pharma

Managing director · since 27 novembre 2019 · until 26 novembre 2025 · 0554.748.443

Represented by Eric Letellier

Ended
Nicolas Sterckx

Director · since 27 novembre 2019 · until 26 novembre 2025

Ended
Letellier Pharma

Director · since 01 juillet 2014 · until 30 juin 2020 · 0554.748.443

Represented by Eric Letellier

Ended
Nicolas Sterckx

Director · since 01 juillet 2014 · until 30 juin 2020

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date31/03/202631/01/202529/01/202428/02/202318/02/202223/02/2021
General meeting26/11/202518/12/202413/12/202314/12/202215/12/202116/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/06/202526/11/202531/03/2026DutchPDF
Abridged model30/06/202418/12/202431/01/2025DutchPDF
Abridged model30/06/202313/12/202329/01/2024DutchPDF
Abridged model30/06/202214/12/202228/02/2023DutchPDF
Abridged model30/06/202115/12/202118/02/2022DutchPDF
Abridged model30/06/202016/12/202023/02/2021DutchPDF
Abridged model30/06/201828/11/201804/02/2019DutchPDF
Abridged model30/06/201722/11/201719/12/2017DutchPDF
Abridged model30/06/201623/11/201627/02/2017DutchPDF
Abridged model30/06/201525/11/201514/12/2015DutchPDF
Abridged model30/06/201426/11/201408/01/2015DutchPDF
Abridged model30/06/201327/11/201312/12/2013DutchPDF
Abridged model30/06/201228/11/201219/12/2012DutchPDF
Abridged model30/06/201123/11/201129/11/2011DutchPDF
Abridged model30/06/201024/11/201002/12/2010DutchPDF
Abridged model30/06/200925/11/200903/12/2009DutchPDF
Abridged model30/06/200817/12/200820/01/2009DutchPDF
Abridged model30/06/200719/12/200728/12/2007DutchPDF
Abridged model30/06/200622/11/200629/01/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

2 active · 13 ended

Active mandates

Letellier Pharma

Managing director · 0554.748.443

Represented by Eric Letellier

Active
Nicolas Sterckx

Director

Active

Ended mandates

Letellier Pharma

Managing director · since 27 novembre 2019 · until 26 novembre 2025 · 0554.748.443

Represented by Eric Letellier

Ended
Nicolas Sterckx

Director · since 27 novembre 2019 · until 26 novembre 2025

Ended
Letellier Pharma

Director · since 01 juillet 2014 · until 30 juin 2020 · 0554.748.443

Represented by Eric Letellier

Ended
Nicolas Sterckx

Director · since 01 juillet 2014 · until 30 juin 2020

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates19/04/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/04/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other12/08/2014
    BENAMING
    PDF
  • Mandates15/07/2014
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/12/2009
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares17/05/2006
    ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates15/12/2003
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202562,9 k €↓
  2. 2024
    Annual accounts 202487,8 k €↑
  3. 2023
    Annual accounts 202383,7 k €↓
  4. 2022
    Annual accounts 2022117,4 k €↑
  5. 2021
    Annual accounts 202160,9 k €↓
  6. 2020
    Annual accounts 202080,7 k €↑
  7. 2018
    Annual accounts 201848,6 k €↓
  8. 2017
    Annual accounts 201769,3 k €↓
  9. 2016
    Annual accounts 201683,1 k €↑
  10. 2015
    Annual accounts 201542,1 k €↓
  11. 2014
    Annual accounts 2014106 k €↑
  12. 2013
    Annual accounts 201354 k €↓
  13. 2012
    Annual accounts 201266,9 k €↑
  14. 2011
    Annual accounts 201146,7 k €↓
  15. 2010
    Annual accounts 201048,2 k €↑
  16. 2008
    Annual accounts 200845,9 k €↓
  17. 2007
    Annual accounts 200748,5 k €
  18. 31/12/1997
    IncorporationPublic limited company